Get started
Work

Measuring the Symptom Burden of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With and Without Acute Graft-Versus-Host Disease

Year: 2009
Type: article
Abstract: Significance: Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an intensive but potentially curative therapy for patients with life-threatening illnesses. During alloHSCT, patients develop symptom burden that substantially interferes with daily activities. Acute graft-versus-host disease (aGVHD) may significantly contribute to symptom burden.
DOI: 10.1016/j.bbmt.2008.12.062
Authors: L.A. Williams, S.A. Giralt, X.S. Wang, G.M. Mobley, T.R. Mendoza, M.Z. Cohen, C.S. Cleeland
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2054679407
FWCI: 0.594
Cites:
Cited by: 8
Related to: 10